Knowledge Ecology International
Attending and mending the knowledge ecosystem
Menu Close
  • About
  • Areas of work
  • Coronavirus
  • Xtandi
  • Listserves
  • Videos
  • Publications
  • Databases
  • Donate
Home»Blogs»Delinking biomedical R&D, including incentives, from monopolies and high prices

Delinking biomedical R&D, including incentives, from monopolies and high prices

Posted on October 5, 2023 by James Love

These are the slides that were used in a KEI-People’s Vaccine Alliance webinar on delinking R&D financing from temporary monopolies.

KEI-PVA-webinar-Delinking-rnd-5oct2023

Access to Medicine, Delinkage

Post navigation

KEI Comments to CMS Regarding Imbruvica (INN:Ibrutinib) R&D (regarding Medicare pricing negotiations)
Scarlet TCR: Comments on a NIH prospective exclusive patent license for treatment of HPV cancers

Categories

  • About
  • Access to Knowledge
  • Access to Medicine
  • AI
  • Competition
  • Delinkage
  • Economics
  • Events
  • Evidence
  • Government Funded research
  • influence
  • Intellectual Property Rights
  • Legislation
  • Litigation
  • Lobbying
  • Marketing
  • Meetings
  • Negotiations
  • Nuclear Proliferation
  • Orphan Drugs
  • Presentations
  • Privacy
  • Public Goods
  • Research and Development
  • Site Articles
  • Timelines
  • Trade
  • Transparency
  • WHO
  • WIPO
  • WTO
© 2025 Knowledge Ecology International. All rights reserved.
Hiero by aThemes